Cadrenal Therapeutics, Inc. Common Stock (CVKD) short interest & short volume · 20.3% of float short
Cadrenal Therapeutics, Inc. Common Stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
CVKD short interest rose 165.6% to 281K shares in the Oct 15, 2026 report (20.3% of float, 1.0 days to cover). Daily short volume averaged 50.5% of volume over the last 20 sessions, up from 39.6% the 20 sessions before, the 55th percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 281K
- prior 106K
- % of float
- 20.3%
- float 1.4M
- Days to cover
- 1.0
- avg vol 310K
- Change vs prior report
- +165.6%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 48.5%
- 90K of 185K
- 20-day average
- 50.5%
- prior 39.6%
- Percentile vs own history
- 55th
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: +16.5%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
CVKD's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · CVKD overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 89,709 | 184,906 | 48.5% |
| 2026-10-30 | 48,679 | 50,443 | 96.5% |
| 2026-10-29 | 10,040 | 37,077 | 27.1% |
| 2026-10-28 | 11,374 | 29,586 | 38.4% |
| 2026-10-27 | 31,456 | 42,119 | 74.7% |
| 2026-10-26 | 14,141 | 35,375 | 40.0% |
| 2026-10-23 | 2,936 | 19,534 | 15.0% |
| 2026-10-22 | 2,965 | 12,342 | 24.0% |
| 2026-10-21 | 6,673 | 18,835 | 35.4% |
| 2026-10-20 | 5,431 | 33,359 | 16.3% |
Healthcare peers with similar quant ratings
CVKD among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- QTTB short interest5.00 · Strong Buy · stock
- AVAH short interest4.99 · Strong Buy · stock
- CDNA short interest4.98 · Strong Buy · stock
- HALO short interest4.97 · Strong Buy · stock
- OSCR short interest4.97 · Strong Buy · stock
- BTSG short interest4.96 · Strong Buy
- REGN short interest4.95 · Strong Buy · stock
- CON short interest4.94 · Strong Buy · stock
CVKD short interest FAQ
What is CVKD's short interest?
Cadrenal Therapeutics, Inc. Common Stock (CVKD) had 281K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 20.3% of its 1.4M-share float.
How many days to cover does CVKD have?
1.0 days: 281K shares short divided by an average daily volume of 310K for the Oct 15, 2026 period.
Is CVKD short interest rising or falling?
CVKD short interest rose (+165.6%) from 106K to 281K shares in the Oct 15, 2026 report.
Is CVKD a short squeeze candidate?
Lician's squeeze watch scores CVKD 58 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 27/40, days to cover 2.5/25, change in short interest vs prior report 15/15, price change since settlement date 13.2/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of CVKD daily volume is sold short?
50.5% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 55th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was CVKD's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Cadrenal Therapeutics, Inc. Common Stock (CVKD) was 89,709 shares, 48.5% of 184,906 total volume.
How many CVKD short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Cadrenal Therapeutics, Inc. Common Stock (CVKD), from Oct 20, 2026 through Nov 2, 2026.
How did CVKD short volume percent change from the prior cached session?
Cached FINRA short volume for Cadrenal Therapeutics, Inc. Common Stock (CVKD) moved from 96.5% on Oct 30, 2026 to 48.5% on Nov 2, 2026, down 48.0 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.